MicroRNA210 Suppresses Mitochondrial Metabolism and Promotes Microglial Activation in Neonatal Hypoxic-Ischemic Brain

Shirley Hu1, Yanelly Lopez-Robles1, Guofang Shen1,2

  • 1The Lawrence D. Longo Center for Perinatal Biology, Department of Basic Sciences, School of Medicine, Loma Linda University, Loma Linda, CA 92350, USA.

Cells
|August 13, 2025
PubMed

Insights

MicroRNA210 (miR210) inhibition protects against neonatal brain injury by reducing neuroinflammation. This study reveals miR210 promotes microglial activation and brain damage by impairing mitochondrial function.

Area of Science:

  • Neuroscience
  • Immunology
  • Molecular Biology

Background:

  • Neonatal hypoxic-ischemic (HI) brain injury involves significant neuroinflammation.
  • MicroRNA210 (miR210) inhibition shows neuroprotective effects after HI.
  • The precise mechanisms by which miR210 influences HI pathology are not fully understood.

Purpose of the Study:

  • To investigate the role of miR210 in microglial activation and neuroinflammation following neonatal HI.
  • To test the hypothesis that miR210 exacerbates HI brain injury by suppressing microglial mitochondrial function.

Main Methods:

  • Utilized miR210 knockout (KO) mice and primary microglial cultures.
  • Induced neonatal HI brain injury in wild-type and miR210 KO mouse pups.
  • Performed in vitro oxygen-glucose deprivation (OGD) on microglial cells.
  • Assessed brain infarct size, locomotor function, inflammatory markers (IL1β), microglial activation, and mitochondrial function (ISCU, oxidative phosphorylation).

Main Results:

  • miR210 KO significantly reduced brain infarct size and improved long-term locomotor function post-HI.
  • miR210 KO mice showed decreased IL1β levels, reduced microglial activation, and less immune cell infiltration.
  • In vitro, miR210 inhibition lessened OGD-induced IL1β expression and restored mitochondrial function.
  • Overexpression of miR210 in microglia mimicked the effects of ISCU silencing, increasing proinflammatory cytokines.

Conclusions:

  • miR210 acts as a key regulator of microglial proinflammatory activation in neonatal HI brain injury.
  • miR210 promotes neuroinflammation and brain damage by negatively impacting microglial mitochondrial function.
  • Targeting miR210 may offer a therapeutic strategy for neonatal HI brain injury.